Firstep MET/MDMA Drug Screen Rapid Test - Taiwan Registration 8425af22ebdaea18d05971ebe3b93faa
Access comprehensive regulatory information for Firstep MET/MDMA Drug Screen Rapid Test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8425af22ebdaea18d05971ebe3b93faa and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
8425af22ebdaea18d05971ebe3b93faa
Ministry of Health Medical Device Manufacturing No. 005597
Product Details
This product uses immunoqualitative analysis methods to test methamphetamine/ecstasy and its metabolites in human urine. The detection threshold for this product is 500 ng/mL. Performance Change: This product uses immunoqualitative analysis methods to test for methamphetamine/ecstasy and its metabolites in human urine. This product can be used by professionals and the general public. The detection threshold for this product is 500 ng/mL.
A Clinical chemistry and clinical toxicology
A3610 Methamphetamine Test System
Produced in Taiwan, China
Dates and Status
Feb 24, 2017
Feb 24, 2027